Rationale and design of a large‐scale, app‐based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.09.002
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi‐morbidity: Insights from the ARISTOTLE trial
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.09.017
Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.05.012
Apixaban versus warfarin in evaluation of progression of atherosclerotic and calcified plaques (prospective randomized trial).
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.02.014
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.04.020
Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patients.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.10.012
C-reactive protein and stroke risk in blacks and whites: The REasons for Geographic And Racial Differences in Stroke cohort.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.08.003
Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.06.001
Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.04.002
Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.05.007
Hybrid comprehensive telerehabilitation in heart failure patients (TELEREH-HF): A randomized, multicenter, prospective, open-label, parallel group controlled trial-Study design and description of the intervention.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.08.015
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.04.006
A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.08.002
Myocardial constructive work and cardiac mortality in resynchronization therapy candidates.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.02.008
Temporal trends, determinants, and impact of high‐intensity statin prescriptions after percutaneous coronary intervention: Results from a large single‐center prospective registry
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.09.001
Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.02.007
Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2019.01.009
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.12.004
A randomized, double‐blind, placebo‐controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.12.015
High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.06.019
Incidence and predictors of atrial fibrillation episodes as detected by implantable loop recorder in patients at risk: From the LOOP study.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.09.009
Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.08.007
Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.02.017
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real‐world cohort of persons with human immunodeficiency virus and uninfected persons
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.11.012
Income level and inequality as complement to geographical differences in cardiovascular trials.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.08.019
Association between the timing of surgery for complicated, left‐sided infective endocarditis and survival
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2019.01.004
Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.12.015
Modes of death and prognostic outliers in chronic heart failure
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.11.009
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.09.017
Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.07.007
Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.06.014
Long-term follow-up and safety assessment of angiogenic gene therapy trial VIF-CAD: Transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165/bFGF cDNA for the treatment of refractory coronary artery disease.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.06.009
Danish study of Non-Invasive testing in Coronary Artery Disease 2 (Dan-NICAD 2): Study design for a controlled study of diagnostic accuracy.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.03.016
Early experiences with cardiology electronic consults: A systematic review.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.06.013
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.11.004
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II).
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.10.015
Rationale and design of a multicenter randomized trial to compare the graft patency between no‐touch vein harvesting technique and conventional approach in coronary artery bypass graft surgery
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.11.011
The effect of metoprolol and aspirin on cardiovascular risk in bereavement: A randomized controlled trial.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.11.003
A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.12.001
Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: Rationale and design of the international Cryo-FIRST study.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.12.006
Twenty‐five year trends (1986–2011) in hospital incidence and case‐fatality rates of ventricular tachycardia and ventricular fibrillation complicating acute myocardial infarction
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.10.007
Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.05.004
Geschichte der Psychiatrie „von unten“: Entwicklung und Stand der deutschsprachigen Forschung. Current Developments and Positions in German-speaking Research
来源期刊：American Heart JournalDOI：10.25162/MHJ-2019-0010
Enhanced radiation exposure associated with anterior-posterior x-ray tube position in young women undergoing cardiac computed tomography.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.05.006
Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development.
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.05.016
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug‐Eluting Stents (ADAPT‐DES) study
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2019.02.002
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.08.016
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS.
来源期刊：American heart journalDOI：10.1016/j.ahj.2019.11.005
Rational and design of the INtentional COronary revascularization versus conservative therapy in patients undergOing successful peripheRAl arTEry revascularization due to critical limb ischemia trial (INCORPORATE trial).
来源期刊：American heart journalDOI：10.1016/J.AHJ.2019.05.005
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension and paroxysmal AF
来源期刊：American Heart JournalDOI：10.1016/j.ahj.2018.09.010
